3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with iodine in 1 studies
Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Studies (iodine) | Trials (iodine) | Recent Studies (post-2010) (iodine) |
---|---|---|---|---|---|
100 | 6 | 38 | 10,338 | 88 | 1,731 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernard, BF; de Jong, M; Docter, R; Hennemann, G; Krenning, EP; Lim, CF | 1 |
1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and iodine
Article | Year |
---|---|
A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.
Topics: Adsorption; Animals; Biological Transport; Cells, Cultured; Furans; Hippurates; Humans; Indican; Iodides; Kidney Failure, Chronic; Liver; Male; Propionates; Rats; Rats, Wistar; Renal Dialysis; Thyroxine; Uremia | 1993 |